{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:19:00Z","timestamp":1783635540441,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00255-4","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:22:31Z","timestamp":1746152551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preliminary results suggest the potential of evaluating combined bFGF and TNF-\u03b2 concentrations for differentiating papillary thyroid cancer from benign nodular goiter"],"prefix":"10.1038","volume":"15","author":[{"given":"Magdalena","family":"\u0106wikli\u0144ska-Dworakowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina Marta","family":"Gacuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Justyna","family":"Milewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Matowicka-Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Martyna","family":"Koper-Lenkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"255_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.f4706","volume":"347","author":"JP Brito","year":"2013","unstructured":"Brito, J. P., Morris, J. C. & Montori, V. M. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ 347, 1\u20136 (2013).","journal-title":"BMJ"},{"key":"255_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.571421","volume":"11","author":"J Krajewska","year":"2020","unstructured":"Krajewska, J. et al. Early diagnosis of Low-Risk papillary thyroid Cancer results rather in overtreatment than a better survival. Front. Endocrinol. (Lausanne). 11, 1\u201315 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"255_CR3","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.eprac.2021.09.006","volume":"27","author":"MR Haymart","year":"2021","unstructured":"Haymart, M. R. Progress and challenges in thyroid Cancer management. Endocr. Pract. 27, 1260\u20131263 (2021).","journal-title":"Endocr. Pract."},{"key":"255_CR4","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/healthcare10091621","volume":"10","author":"D Horgan","year":"2022","unstructured":"Horgan, D. et al. Tackling thyroid Cancer in Europe\u2014The challenges and opportunities. Healthcare 10, 1621 (2022).","journal-title":"Healthcare"},{"key":"255_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/clinem\/dgac646","volume":"108","author":"TM Ullmann","year":"2023","unstructured":"Ullmann, T. M., Papaleontiou, M. & Sosa, J. A. Current controversies in Low-Risk differentiated thyroid cancer: reducing overtreatment in an era of overdiagnosis. J. Clin. Endocrinol. Metab. 108, 271\u2013280 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"255_CR6","doi-asserted-by":"publisher","first-page":"R465","DOI":"10.1530\/ERC-19-0163","volume":"26","author":"F Coperchini","year":"2019","unstructured":"Coperchini, F., Croce, L., Marin\u00f2, M., Chiovato, L. & Rotondi, M. Role of chemokine receptors in thyroid cancer and immunotherapy. Endocr. Relat. Cancer. 26, R465\u2013R478 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"255_CR7","doi-asserted-by":"crossref","unstructured":"Xi, C. et al. Interleukins in thyroid cancer: from basic researches to applications in clinical practice. Front. Immunol. 11, (2020).","DOI":"10.3389\/fimmu.2020.01124"},{"key":"255_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.31557\/APJCP.2019.20.1.277","volume":"20","author":"NH Mohamad Pakarul Razy","year":"2019","unstructured":"Mohamad Pakarul Razy, N. H., Rahman, W. F. W. A. & Win, T. T. Expression of vascular endothelial growth factor and its receptors in thyroid nodular hyperplasia and papillary thyroid carcinoma: A tertiary health care centre based study. Asian Pac. J. Cancer Prev. 20, 277\u2013282 (2019).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"255_CR9","doi-asserted-by":"publisher","first-page":"155828","DOI":"10.1016\/j.cyto.2022.155828","volume":"153","author":"K Matsushima","year":"2022","unstructured":"Matsushima, K., Yang, D. & Oppenheim, J. J. Interleukin-8: an evolving chemokine. Cytokine 153, 155828 (2022).","journal-title":"Cytokine"},{"key":"255_CR10","unstructured":"American Thyroid Association. https:\/\/www.thyroid.org\/cancer-of-the-thyroid\/."},{"key":"255_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/10543406.2020.1832107","volume":"31","author":"X Hu","year":"2021","unstructured":"Hu, X., Li, C., Chen, J. & Qin, G. Confidence intervals for the Youden index and its optimal cut-off point in the presence of covariates. J. Biopharm. Stat. 31, 251\u2013272 (2021).","journal-title":"J. Biopharm. Stat."},{"key":"255_CR12","first-page":"27","volume":"169","author":"R Ria","year":"2021","unstructured":"Ria, R. et al. Effect of thyroidectomy on Circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: potential for new biomarkers? Surg. (United States). 169, 27\u201333 (2021).","journal-title":"Surg. (United States)"},{"key":"255_CR13","doi-asserted-by":"crossref","unstructured":"Kobawala, T. P. et al. Significance of TNF- \u03b1 and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma. J. Thyroid Res. 1\u201317 (2016).","DOI":"10.1155\/2016\/8143695"},{"key":"255_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-020-00931-1","volume":"15","author":"H Lu","year":"2020","unstructured":"Lu, H. et al. Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma. Diagn. Pathol. 15, 1\u20139 (2020).","journal-title":"Diagn. Pathol."},{"key":"255_CR15","first-page":"1","volume":"20","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Li, S., Wang, J., Liu, F. & Zhao, Y. Relationship between serum inflammatory factor levels and differentiated thyroid carcinoma. Technol. Cancer Res. Treat. 20, 1\u20138 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"key":"255_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/bcpt.13076","volume":"123","author":"Y Xu","year":"2018","unstructured":"Xu, Y. et al. miR-27b\u20103p is involved in doxorubicin resistance of human anaplastic thyroid Cancer cells via targeting peroxisome Proliferator\u2010Activated receptor gamma. Basic. Clin. Pharmacol. Toxicol. 123, 670\u2013677 (2018).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"255_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/172460081002500106","volume":"25","author":"H Liang","year":"2010","unstructured":"Liang, H. et al. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. Int. J. Biol. Markers. 25, 38\u201345 (2010).","journal-title":"Int. J. Biol. Markers"},{"key":"255_CR18","first-page":"1","volume":"11","author":"MS Ummah","year":"2019","unstructured":"Ummah, M. S. [Clinical significance of expression of VEGF and bFGF in thyroid carcinoma]. Sustain 11, 1\u201314 (2019).","journal-title":"Sustain"},{"key":"255_CR19","doi-asserted-by":"publisher","first-page":"e20644","DOI":"10.1097\/MD.0000000000020644","volume":"99","author":"ZY Jia","year":"2020","unstructured":"Jia, Z. Y., Wu, X. L., Zhang, Y. H., Ma, B. L. & Ma, F. C. The correlation between ultrasonographic features, bFGF, and the local invasiveness of thyroid papillary carcinoma. Med. (Baltim). 99, e20644 (2020).","journal-title":"Med. (Baltim)."},{"key":"255_CR20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-015-1705-5","volume":"64","author":"S Zivancevic-Simonovic","year":"2015","unstructured":"Zivancevic-Simonovic, S. et al. Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis. Cancer Immunol. Immunother. 64, 1011\u20131019 (2015).","journal-title":"Cancer Immunol. Immunother"},{"key":"255_CR21","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1080\/21645515.2019.1710413","volume":"16","author":"N Zheng","year":"2020","unstructured":"Zheng, N. & Lu, Y. Targeting the IL-9 pathway in cancer immunotherapy. Hum. Vaccines Immunother. 16, 2333\u20132340 (2020).","journal-title":"Hum. Vaccines Immunother"},{"key":"255_CR22","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s12253-019-00665-6","volume":"26","author":"JE Lee","year":"2020","unstructured":"Lee, J. E. et al. The role of Interleukin-9 in Cancer. Pathol. Oncol. Res. 26, 2017\u20132022 (2020).","journal-title":"Pathol. Oncol. Res."},{"key":"255_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04821-2","author":"X Ying","year":"2024","unstructured":"Ying, X., Ma, X., Yang, Z. & Zhou, B. Th9 cytokines inhibit proliferation, promote apoptosis, and immune escape in thyroid carcinoma cells. Appl. Biochem. Biotechnol. https:\/\/doi.org\/10.1007\/s12010-023-04821-2 (2024).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"255_CR24","first-page":"71","volume":"19","author":"Z Amirkhani","year":"2022","unstructured":"Amirkhani, Z., Alavi, M., Kalani, M., Alavianmehr, A. & Farjadian, S. Immunomodulatory effects of Omega-3 fatty acids in patients with differentiated thyroid Cancer before or after radioiodine ablation. Iran. J. Immunol. 19, 71\u201390 (2022).","journal-title":"Iran. J. Immunol."},{"key":"255_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00262-014-1619-7","volume":"64","author":"SZ Simonovic","year":"2015","unstructured":"Simonovic, S. Z. et al. Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2\/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy. Cancer Immunol. Immunother. 64, 75\u201382 (2015).","journal-title":"Cancer Immunol. Immunother"},{"key":"255_CR26","doi-asserted-by":"publisher","unstructured":"Kobawala, T., Trivedi, T., Gajjar, K., Patel, G. & Ghosh, N. Role of Interleukin-18 in thyroid tumorigenesis role of Interleukin-18 in thyroid tumorigenesis. (2016). https:\/\/doi.org\/10.14319\/ijcto.44.1","DOI":"10.14319\/ijcto.44.1"},{"key":"255_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI166028","volume":"133","author":"JE Jaspers","year":"2023","unstructured":"Jaspers, J. E. et al. IL-18-secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models. J. Clin. Invest. 133, 1\u201311 (2023).","journal-title":"J. Clin. Invest."},{"key":"255_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1535370218824538","volume":"244","author":"C Buhrmann","year":"2019","unstructured":"Buhrmann, C. et al. Evidence that TNF-\u03b2 induces proliferation in colorectal cancer cells and Resveratrol can down-modulate it. Exp. Biol. Med. 244, 1\u201312 (2019).","journal-title":"Exp. Biol. Med."},{"key":"255_CR29","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.3390\/cancers13143609","volume":"13","author":"DC Gheorghe","year":"2021","unstructured":"Gheorghe, D. C., Stanciu, M. M., Zamfirescu, A. & Stanciu, A. E. TNF-\u03b1 May exert different antitumor effects in response to radioactive iodine therapy in papillary thyroid Cancer with\/without autoimmune thyroiditis. Cancers (Basel). 13, 3609 (2021).","journal-title":"Cancers (Basel)"},{"key":"255_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cyto.2010.03.005","volume":"50","author":"F Lumachi","year":"2010","unstructured":"Lumachi, F., Basso, S. M. M. & Orlando, R. Cytokines, thyroid diseases and thyroid cancer. Cytokine 50, 229\u2013233 (2010).","journal-title":"Cytokine"},{"key":"255_CR31","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.7150\/jca.53349","volume":"12","author":"N Lv","year":"2021","unstructured":"Lv, N., Liu, F., Cheng, L., Liu, F. & Kuang, J. The expression of transcription factors is different in papillary thyroid Cancer cells during TNF - \u03b1 induced EMT. J. Cancer. 12, 2777\u20132786 (2021).","journal-title":"J. Cancer"},{"key":"255_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/03008207.2015.1060970","volume":"56","author":"J Banyard","year":"2015","unstructured":"Banyard, J. & Bielenberg, D. R. The role of EMT and MET in cancer dissemination. Connect. Tissue Res. 56, 403\u2013413 (2015).","journal-title":"Connect. Tissue Res."},{"key":"255_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000341690","volume":"30","author":"J Bauer","year":"2012","unstructured":"Bauer, J. et al. NF-\u0138B, and cancer: the dark side of cytokines. Dig. Dis. 30, 453\u2013468 (2012). Lymphotoxin.","journal-title":"Dig. Dis."},{"key":"255_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2014.02.001","volume":"25","author":"NH Ruddle","year":"2014","unstructured":"Ruddle, N. H. & Lymphotoxin How it all began-A tribute to the travelers. Cytokine Growth Factor. Rev. 25, 83\u201389 (2014).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"255_CR35","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbcan.2016.02.005","volume":"1865","author":"MT Fernandes","year":"2016","unstructured":"Fernandes, M. T., Dejardin, E. & dos Santos, N. R. Context-dependent roles for lymphotoxin-\u03b2 receptor signaling in cancer development. Biochim. Biophys. Acta - Rev. Cancer. 1865, 204\u2013219 (2016).","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"255_CR36","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/humrep\/der301","volume":"26","author":"SK Lee","year":"2011","unstructured":"Lee, S. K. et al. An imbalance in interleukin-17-producing T and Foxp3\u2009+\u2009regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum. Reprod. 26, 2964\u20132971 (2011).","journal-title":"Hum. Reprod."},{"key":"255_CR37","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1469-0691.2011.03490.x","volume":"17","author":"Y Tang","year":"2011","unstructured":"Tang, Y. et al. Evaluation of Th1\/Th2 cytokines as a rapid diagnostic tool for severe infection in paediatric haematology\/oncology patients by the use of cytometric bead array technology. Clin. Microbiol. Infect. 17, 1666\u20131673 (2011).","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00255-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:22:38Z","timestamp":1746152558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00255-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00255-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"28 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research followed the guidelines set forth in the Declaration of Helsinki, and the protocol was approved by the Bioethics Human Research Committee at the Medical University of Bialystok (Permission No. APK.002.356.2022). Before participating in the study, all individuals provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15316"}}